Cargando…

A Carrier for Non-Covalent Delivery of Functional Beta-Galactosidase and Antibodies against Amyloid Plaques and IgM to the Brain

BACKGROUND: Therapeutic intervention of numerous brain-associated disorders currently remains unrealized due to serious limitations imposed by the blood-brain-barrier (BBB). The BBB generally allows transport of small molecules, typically <600 daltons with high octanol/water partition coefficient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarkar, Gobinda, Curran, Geoffry L., Mahlum, Eric, Decklever, Teresa, Wengenack, Thomas M., Blahnik, Anthony, Hoesley, Bridget, Lowe, Val J., Poduslo, Joseph F., Jenkins, Robert B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244419/ https://www.ncbi.nlm.nih.gov/pubmed/22216132 http://dx.doi.org/10.1371/journal.pone.0028881

Ejemplares similares

Peptide Carrier-Mediated Non-Covalent Delivery of Unmodified Cisplatin, Methotrexate and Other Agents via Intravenous Route to the Brain
por: Sarkar, Gobinda, et al.
Publicado: (2014)

HH Domain of Alzheimer’s Disease Aβ Provides Structural Basis for Neuronal Binding in PC12 and Mouse Cortical/Hippocampal Neurons
por: Poduslo, Joseph F., et al.
Publicado: (2010)

Improving Properties of a Novel β-Galactosidase from Lactobacillus plantarum by Covalent Immobilization
por: Benavente, Rocio, et al.
Publicado: (2015)

Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice
por: Xu, Ming, et al.
Publicado: (2017)

Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
por: Hashimoto, Tadafumi, et al.
Publicado: (2020)

Carrier-Free Immobilization of α-Galactosidase as Nano-Biocatalysts for Synthesizing Prebiotic α-Galacto-Oligosaccharides
por: Liu, Yan, et al.
Publicado: (2021)

Prevention of Bacterial Contamination of a Silica Matrix Containing Entrapped β-Galactosidase through the Action of Covalently Bound Lysozymes
por: Li, Heng, et al.
Publicado: (2017)

Mechanism of Neuronal versus Endothelial Cell Uptake of Alzheimer's Disease Amyloid β Protein
por: Kandimalla, Karunya K., et al.
Publicado: (2009)

Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier – phenotypic variability in autosomal dominant Alzheimer’s disease
por: Lloyd, Grace M., et al.
Publicado: (2020)

p-Phenylene Diisothiocyanate-Based Covalent Immobilization of β-d-Galactosidase and Determination of Enzyme Activity by Cleavage of X-Gal and ONPG on Solid Support
por: Dayi, Defne I., et al.
Publicado: (2023)

Development of the covalent antibody-DNA conjugates technology for detection of IgE and IgM antibodies by immuno-PCR
por: Maerle, Artem V., et al.
Publicado: (2019)

New α-galactosidase-inhibiting aminohydroxycyclopentanes
por: Weber, Patrick, et al.
Publicado: (2021)

A Proteomic Atlas of Cardiac Amyloid Plaques
por: Kourelis, Taxiarchis V., et al.
Publicado: (2020)

Exosomes as Carriers of Alzheimer's Amyloid-ß
por: Yuyama, Kohei, et al.
Publicado: (2017)

Repeated treatments with rituximab in a patient with amyloid-like IgM deposition neuropathy
por: Kadoya, Masato, et al.
Publicado: (2016)

Analysis by a plaque assay of IgG- or IgM- dependent cytolytic lymphocytes in human blood
Publicado: (1976)

Intranasal neprilysin rapidly eliminates amyloid-beta plaques, but causes plaque compensations: the explanation why the amyloid-beta cascade may fail?
por: Humpel, Christian
Publicado: (2022)

A covalent homodimer probing early oligomers along amyloid aggregation
por: Halabelian, Levon, et al.
Publicado: (2015)

High Throughput Screening for Inhibitors of Alpha-Galactosidase
por: Motabar, Omid, et al.
Publicado: (2010)

β-galactosidase stability at high substrate concentrations
por: Warmerdam, Anja, et al.
Publicado: (2013)

Bioconversion of Beet Molasses to Alpha-Galactosidase and Ethanol
por: Álvarez-Cao, María-Efigenia, et al.
Publicado: (2019)

Mutation patterns in human α-galactosidase A
por: Yan, Shaomin, et al.
Publicado: (2009)

Senescence-Associated β-Galactosidase Detection in Pathology
por: Valieva, Yana, et al.
Publicado: (2022)

Interactions between Amyloid-β and Hemoglobin: Implications for Amyloid Plaque Formation in Alzheimer's Disease
por: Chuang, Jia-Ying, et al.
Publicado: (2012)

Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation
por: Stewart, Katie L., et al.
Publicado: (2017)

New amyloid plaques or a game of hide-and-seek?
por: Zou, Kun, et al.
Publicado: (2008)

Amyloid plaque formation precedes dendritic spine loss
por: Bittner, Tobias, et al.
Publicado: (2012)

Fibrillar Amyloid Plaque Formation Precedes Microglial Activation
por: Jung, Christian K. E., et al.
Publicado: (2015)

Florbetaben for PET Imaging of Beta-Amyloid Plaques in the Brain
por: Richards, Danielle, et al.
Publicado: (2014)

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
por: Querol-Vilaseca, Marta, et al.
Publicado: (2019)

Optical Imaging of Beta-Amyloid Plaques in Alzheimer’s Disease
por: Luo, Ziyi, et al.
Publicado: (2021)

Association between IgM Anti-Herpes Simplex Virus and Plasma Amyloid-Beta Levels
por: Féart, Catherine, et al.
Publicado: (2011)

IgM response against amyloid-beta in aging: a potential peripheral protective mechanism
por: Agrawal, Sudhanshu, et al.
Publicado: (2018)

A non-covalent peptide-based carrier for in vivo delivery of DNA mimics
por: Morris, May C., et al.
Publicado: (2007)

Artificial covalent linkage of bacterial acyl carrier proteins for fatty acid production
por: Rullán-Lind, Carlos, et al.
Publicado: (2019)

Defects in Mitochondrial Dynamics and Metabolomic Signatures of Evolving Energetic Stress in Mouse Models of Familial Alzheimer's Disease
por: Trushina, Eugenia, et al.
Publicado: (2012)

A 23-Year-Old Man with Hyper-IgM Syndrome Presenting with Asymptomatic Violaceous Facial Plaques
por: Barrios, Mirelys, et al.
Publicado: (2020)

PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer’s disease-causing Presenilin-1 E280A mutation carriers
por: Ghisays, Valentina, et al.
Publicado: (2021)

Phosphorylation of covalent organic framework nanospheres for inhibition of amyloid-β peptide fibrillation
por: Yao, Linli, et al.
Publicado: (2022)

Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane
por: Zhang, Liang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aiu3t2kkctrv0vmudh678rd0ra